{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:40:11Z","timestamp":1793648411897,"version":"4.5.1"},"reference-count":77,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ersjournals.com"],"crossmark-restriction":true},"short-container-title":["Breathe"],"accepted":{"date-parts":[[2024,7,15]]},"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:p>Bone marrow transplantation, now often known as haematopoietic stem cell transplantation (HSCT), is a complex choreographed procedure used to treat both acquired and inherited disorders of the bone marrow. It has proven invaluable as therapy for haematological and immunological disorders, and more recently in the treatment of metabolic and enzyme disorders. As the number of performed transplants grows annually, and with patients enjoying improved survival, a knowledge of both early and late complications of HSCT is essential for respiratory trainees and physicians in practice. This article highlights the spectrum of respiratory complications, both infectious and non-infectious, the timeline of their likely occurrence, and the approaches used for diagnosis and treatment, keeping in mind that more than one entity may occur simultaneously. As respiratory issues are often a leading cause of short- and long-term morbidity, consideration of a combined haematology\/respiratory clinic may prove useful in this patient population.<\/jats:p>","DOI":"10.1183\/20734735.0043-2024","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T14:25:20Z","timestamp":1727792720000},"page":"240043","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Pulmonary complications of bone marrow transplantation"],"prefix":"10.1183","volume":"20","author":[{"given":"Helen","family":"O'Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7203-7580","authenticated-orcid":false,"given":"Nina","family":"Orfali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruairi J.","family":"Fahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"2024121802050862000_20.3.240043.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V49.4.511.511"},{"key":"2024121802050862000_20.3.240043.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403243301206"},{"key":"2024121802050862000_20.3.240043.3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41409-023-01943-3","article-title":"Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A report from the EBMT Activity Survey","volume":"58","author":"Passweg","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"2024121802050862000_20.3.240043.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.04.013"},{"key":"2024121802050862000_20.3.240043.5","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41409-022-01691-w","article-title":"Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022","volume":"57","author":"Snowden","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"2024121802050862000_20.3.240043.6","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbmt.2020.03.002","article-title":"Indications for hematopoietic cell transplantation and immune effector cell therapy: guidelines from the American Society for Transplantation and Cellular Therapy","volume":"26","author":"Kanate","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024121802050862000_20.3.240043.7","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.163"},{"key":"2024121802050862000_20.3.240043.8","doi-asserted-by":"crossref","first-page":"1320692","DOI":"10.3389\/fmed.2023.1320692","article-title":"Acute graft versus host disease 1976\u20132020: reduced incidence and predictive factors","volume":"10","author":"Di Francesco","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2024121802050862000_20.3.240043.9","doi-asserted-by":"crossref","first-page":"e0282753","DOI":"10.1371\/journal.pone.0282753","article-title":"Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease","volume":"18","author":"Novitzky-Basso","year":"2023","journal-title":"PLoS One"},{"key":"2024121802050862000_20.3.240043.10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-514752"},{"key":"2024121802050862000_20.3.240043.11","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2014.0123"},{"key":"2024121802050862000_20.3.240043.12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41409-020-0986-2","article-title":"Comparison of reduced-toxicity conditioning protocols using fludarabine, melphalan combined with thiotepa or carmustine in allogeneic hematopoietic cell transplantation","volume":"56","author":"Duque-Afonso","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"2024121802050862000_20.3.240043.13","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.3390\/jcm10153227","article-title":"Pulmonary complications in hematopoietic stem cell transplant recipients \u2013 a clinician primer","volume":"10","author":"Astashchanka","year":"2021","journal-title":"J Clin Med"},{"key":"2024121802050862000_20.3.240043.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.05.022"},{"key":"2024121802050862000_20.3.240043.15","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.bbmt.2015.08.030","article-title":"Engraftment syndrome after autologous stem cell transplantation: an update unifying the definition and management approach","volume":"21","author":"Cornell","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024121802050862000_20.3.240043.16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12032-022-01894-7","article-title":"Engraftment syndrome following hematopoietic stem cell transplantation: a systematic approach toward diagnosis and management","volume":"40","author":"Maqbool","year":"2022","journal-title":"Med Oncol"},{"key":"2024121802050862000_20.3.240043.17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1513\/AnnalsATS.202008-1032OC","article-title":"Characteristics and outcome of periengraftment respiratory distress syndrome after autologous hematopoietic cell transplant","volume":"18","author":"Wieruszewski","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2024121802050862000_20.3.240043.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpa.2007.01.003"},{"key":"2024121802050862000_20.3.240043.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2012.04.001"},{"key":"2024121802050862000_20.3.240043.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(89)80606-0"},{"key":"2024121802050862000_20.3.240043.21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200208-792OC"},{"key":"2024121802050862000_20.3.240043.22","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.189134"},{"key":"2024121802050862000_20.3.240043.23","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/s41409-021-01293-y","article-title":"Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation","volume":"56","author":"Wu","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"2024121802050862000_20.3.240043.24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2007-413ST"},{"key":"2024121802050862000_20.3.240043.25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1597"},{"key":"2024121802050862000_20.3.240043.26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jtct.2022.03.015","article-title":"Noninfectious pulmonary toxicity after allogeneic hematopoietic cell transplantation","volume":"28","author":"Patel","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"2024121802050862000_20.3.240043.27","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.bbmt.2017.07.019","article-title":"Etanercept and corticosteroid therapy for the treatment of late-onset idiopathic pneumonia syndrome","volume":"23","author":"Thompson","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024121802050862000_20.3.240043.28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/bjh.18763","article-title":"Post-transplant lymphoproliferative disorder: update on treatment and novel therapies","volume":"201","author":"Atallah-Yunes","year":"2023","journal-title":"Br J Haematol"},{"key":"2024121802050862000_20.3.240043.29","doi-asserted-by":"crossref","first-page":"53.e1","DOI":"10.1016\/j.jtct.2021.09.021","article-title":"Risk factors for the incidence of and the mortality due to post-transplant lymphoproliferative disorder after hematopoietic cell transplantation","volume":"28","author":"Kinzel","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"2024121802050862000_20.3.240043.30","doi-asserted-by":"crossref","first-page":"7542","DOI":"10.3390\/jcm11247542","article-title":"Post-transplant lymphoproliferative disease (PTLD) after allogeneic hematopoietic stem cell transplantation: biology and treatment options","volume":"11","author":"Clerico","year":"2022","journal-title":"J Clin Med"},{"key":"2024121802050862000_20.3.240043.31","doi-asserted-by":"crossref","first-page":"e1274","DOI":"10.1097\/MD.0000000000001274","article-title":"Posttransplant lymphoproliferative disorder of the thorax: CT and FDG-PET features in a single tertiary referral center","volume":"94","author":"Yoon","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2024121802050862000_20.3.240043.32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jtct.2022.11.012","article-title":"Noninfectious pulmonary complications after hematopoietic stem cell transplantation","volume":"29","author":"Fraebel","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"2024121802050862000_20.3.240043.33","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s00277-019-03746-3","article-title":"Bronchoscopic features, associations, and outcomes of organizing pneumonia following allogeneic hematopoietic stem cell transplantation","volume":"98","author":"Brownback","year":"2019","journal-title":"Ann Hematol"},{"key":"2024121802050862000_20.3.240043.34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1813"},{"key":"2024121802050862000_20.3.240043.35","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/diagnostics10050262","article-title":"Cryptogenic organizing pneumonia: evolution of morphological patterns assessed by HRCT","volume":"10","author":"Tiralongo","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"2024121802050862000_20.3.240043.36","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0119-2019"},{"key":"2024121802050862000_20.3.240043.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.12.001"},{"key":"2024121802050862000_20.3.240043.38","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bbmt.2019.12.002","article-title":"Early post-transplantation spirometry is associated with the development of bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation","volume":"26","author":"Jamani","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024121802050862000_20.3.240043.39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.2017.9938","article-title":"Effect of azithromycin on airflow decline-free survival after allogeneic hematopoietic stem cell transplant: the ALLOZITHRO randomized clinical trial","volume":"318","author":"Bergeron","year":"2017","journal-title":"JAMA"},{"key":"2024121802050862000_20.3.240043.40","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1164\/rccm.201410-1818OC","article-title":"Budesonide\/formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation","volume":"191","author":"Bergeron","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2024121802050862000_20.3.240043.41","doi-asserted-by":"crossref","first-page":"264.e1","DOI":"10.1016\/j.jtct.2022.01.021","article-title":"Prospective phase II trial of montelukast to treat bronchiolitis obliterans syndrome after hematopoietic cell transplantation and investigation into bronchiolitis obliterans syndrome pathogenesis","volume":"28","author":"Williams","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"2024121802050862000_20.3.240043.42","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01727-2023"},{"key":"2024121802050862000_20.3.240043.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-017-0081-5"},{"key":"2024121802050862000_20.3.240043.44","doi-asserted-by":"crossref","first-page":"1086006","DOI":"10.3389\/fimmu.2023.1086006","article-title":"Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers","volume":"14","author":"Bojanic","year":"2023","journal-title":"Front Immunol"},{"key":"2024121802050862000_20.3.240043.45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41409-022-01859-4","article-title":"Interstitial lung diseases after hematopoietic stem cell transplantation: new pattern of lung chronic graft-versus-host disease?","volume":"58","author":"Archer","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"2024121802050862000_20.3.240043.46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/bmt.2010.129","article-title":"Air-leak syndrome following allo-SCT in adult patients: report from the Kanto Study Group for Cell Therapy in Japan","volume":"46","author":"Sakai","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"2024121802050862000_20.3.240043.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.07.017"},{"key":"2024121802050862000_20.3.240043.48","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704426"},{"key":"2024121802050862000_20.3.240043.49","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.cmi.2022.03.032","article-title":"Safe design and maintenance of bone marrow transplant units: a narrative review","volume":"28","author":"Inkster","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2024121802050862000_20.3.240043.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2010.01.010"},{"key":"2024121802050862000_20.3.240043.51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MOT.0000000000000549","article-title":"Pulmonary infectious complications after hematopoietic stem cell transplantation: a practical guide to clinicians","volume":"23","author":"Gea-Banacloche","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"2024121802050862000_20.3.240043.52","first-page":"CD010189","article-title":"Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults","volume":"4","author":"Holtick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2024121802050862000_20.3.240043.53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-096966"},{"key":"2024121802050862000_20.3.240043.54","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbmt.2017.08.024","article-title":"Pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation: impact of T cell-replete transplantation from a haploidentical donor","volume":"24","author":"Mikulska","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024121802050862000_20.3.240043.55","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jiac.2016.05.006","article-title":"An overview of infectious complications after allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Sahin","year":"2016","journal-title":"J Infect Chemother"},{"key":"2024121802050862000_20.3.240043.56","doi-asserted-by":"crossref","first-page":"E629","DOI":"10.1111\/j.1399-0012.2011.01495.x","article-title":"Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study","volume":"25","author":"Aguilar-Guisado","year":"2011","journal-title":"Clin Transplant"},{"key":"2024121802050862000_20.3.240043.57","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jiac.2023.04.015","article-title":"Clinical characteristics and risk factors of pneumococcal diseases in recipients of allogeneic hematopoietic stem cell transplants in the late phase: a retrospective registry study","volume":"29","author":"Okinaka","year":"2023","journal-title":"J Infect Chemother"},{"key":"2024121802050862000_20.3.240043.58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1399-3062.2003.00007.x","article-title":"Systemic nocardiosis following allogeneic bone marrow transplantation","volume":"5","author":"Daly","year":"2003","journal-title":"Transpl Infect Dis"},{"key":"2024121802050862000_20.3.240043.59","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw241"},{"key":"2024121802050862000_20.3.240043.60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/tid.12499","article-title":"Nocardiosis following hematopoietic stem cell transplantation","volume":"18","author":"Shannon","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"2024121802050862000_20.3.240043.61","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1038\/s41409-021-01329-3","article-title":"Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study","volume":"56","author":"de Oliveira Rodrigues","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"2024121802050862000_20.3.240043.62","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1016\/S1473-3099(22)00227-4","article-title":"Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia","volume":"22","author":"Bergeron","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2024121802050862000_20.3.240043.63","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/pathogens12050726","article-title":"Bacterial pathogens causing pneumonia post hematopoietic stem cell transplant: the chronic GVHD population","volume":"12","author":"Chaaban","year":"2023","journal-title":"Pathogens"},{"key":"2024121802050862000_20.3.240043.64","doi-asserted-by":"crossref","first-page":"114.e1","DOI":"10.1016\/j.jtct.2023.09.017","article-title":"Incidence and impact of fungal infections in post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical hematopoietic cell transplantation: a Center for International Blood and Marrow Transplant Research analysis","volume":"30","author":"Papanicolaou","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"2024121802050862000_20.3.240043.65","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.316"},{"key":"2024121802050862000_20.3.240043.66","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ccm.2017.07.013","article-title":"Respiratory fungal infections in solid organ and hematopoietic stem cell transplantation","volume":"38","author":"De La Cruz","year":"2017","journal-title":"Clin Chest Med"},{"key":"2024121802050862000_20.3.240043.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.02.012"},{"key":"2024121802050862000_20.3.240043.68","first-page":"20499361211039050","article-title":"Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management","volume":"8","author":"Rahi","year":"2021","journal-title":"Ther Adv Infect Dis"},{"key":"2024121802050862000_20.3.240043.69","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.idc.2019.02.012","article-title":"Herpes virus infections other than cytomegalovirus in the recipients of hematopoietic stem cell transplantation","volume":"33","author":"Dadwal","year":"2019","journal-title":"Infect Dis Clin North Am"},{"key":"2024121802050862000_20.3.240043.70","doi-asserted-by":"crossref","first-page":"e13061","DOI":"10.1111\/tid.13061","article-title":"Effectiveness of acyclovir prophylaxis against varicella zoster virus disease after allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis","volume":"21","author":"Wada-Shimosato","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"2024121802050862000_20.3.240043.71","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.9053"},{"key":"2024121802050862000_20.3.240043.72","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(03)00287-8"},{"key":"2024121802050862000_20.3.240043.73","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12878-015-0028-2","article-title":"Use of valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation","volume":"15","author":"Ong","year":"2015","journal-title":"BMC Hematol"},{"key":"2024121802050862000_20.3.240043.74","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jtct.2021.09.010","article-title":"American Society for Transplantation and Cellular Therapy Series: #4 \u2013 Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation","volume":"27","author":"Yong","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"2024121802050862000_20.3.240043.75","doi-asserted-by":"crossref","first-page":"106493","DOI":"10.1016\/j.rmed.2021.106493","article-title":"Major pulmonary complications following hematopoietic stem cell transplantation: what the pulmonologist needs to know","volume":"185","author":"Shiari","year":"2021","journal-title":"Respir Med"},{"key":"2024121802050862000_20.3.240043.76","doi-asserted-by":"crossref","first-page":"1125030","DOI":"10.3389\/fimmu.2023.1125030","article-title":"Outcome of COVID-19 in allogeneic stem cell transplant recipients: results from the EPICOVIDEHA registry","volume":"14","author":"Busca","year":"2023","journal-title":"Front Immunol"},{"key":"2024121802050862000_20.3.240043.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2022.101399"}],"container-title":["Breathe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/20734735.0043-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T05:06:42Z","timestamp":1734498402000},"score":1,"resource":{"primary":{"URL":"http:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/20734735.0043-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":77,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,10,1]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1183\/20734735.0043-2024"],"URL":"https:\/\/doi.org\/10.1183\/20734735.0043-2024","relation":{},"ISSN":["1810-6838","2073-4735"],"issn-type":[{"value":"1810-6838","type":"print"},{"value":"2073-4735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}